In the preceding three months, 10 analysts have released ratings for Ameren AEE, presenting a wide array of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 4 | 4 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 1 | 0 | 1 | 0 | 0 |
| 2M Ago | 0 | 4 | 1 | 0 | 0 |
| 3M Ago | 1 | 0 | 1 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Ameren, presenting an average target of $106.3, a high estimate of $114.00, and a low estimate of $100.00. Observing a 1.13% increase, the current average has risen from the previous average price target of $105.11.
Analyzing Analyst Ratings: A Detailed Breakdown
The perception of Ameren by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Stephen Byrd | Morgan Stanley | Lowers | Equal-Weight | $100.00 | $102.00 |
| Daniel Ford | UBS | Raises | Buy | $114.00 | $113.00 |
| Stephen Byrd | Morgan Stanley | Lowers | Equal-Weight | $102.00 | $103.00 |
| Neil Kalton | Wells Fargo | Raises | Overweight | $112.00 | $108.00 |
| Sophie Karp | Keybanc | Announces | Overweight | $103.00 | - |
| Nicholas Campanella | Barclays | Raises | Equal-Weight | $104.00 | $101.00 |
| James Thalacker | BMO Capital | Raises | Outperform | $108.00 | $106.00 |
| James Thalacker | BMO Capital | Raises | Outperform | $106.00 | $105.00 |
| Nicholas Campanella | Barclays | Lowers | Equal-Weight | $101.00 | $102.00 |
| Daniel Ford | UBS | Raises | Buy | $113.00 | $106.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Ameren. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Ameren compared to the broader market.
- Price Targets: Gaining insights, analysts provide estimates for the future value of Ameren's stock. This comparison reveals trends in analysts' expectations over time.
To gain a panoramic view of Ameren's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Ameren analyst ratings.
Unveiling the Story Behind Ameren
Ameren owns rate-regulated generation, transmission, and distribution networks that deliver electricity and natural gas in Missouri and Illinois. It serves 2.5 million electricity customers and approximately 1 million natural gas customers.
Ameren's Economic Impact: An Analysis
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: Ameren's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 15.47%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Utilities sector.
Net Margin: Ameren's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 13.78%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Ameren's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 2.38%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Ameren's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.64%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.61.
The Core of Analyst Ratings: What Every Investor Should Know
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
